Recent Advances in Treating Endometrial and Cervical Cancers - Episode 2

Updated NCCN Guidelines for the Treatment of Advanced or Recurrent Endometrial Cancer

, , , ,

Key opinion leaders review recent updates to the NCCN guidelines for treating recurrent and advanced endometrial cancer, including biomarker testing and targeted therapies like dostarlimab and trastuzumab.